Patent · US Active

Gingko diterpene lactone composition

US11564904B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

JIANGSU KANION PHARMACEUTICAL CO., LTD · CN

Inventors

Wei Xiao · Raleigh, US
Xiujuan CHANG · 安丰镇, CN
Enli Zhou · 安丰镇, CN
Xiaodong Kang · 安丰镇, CN
Yongxiang Wang · Shanghai, CN
Hanfei Hu · 安丰镇, CN
Yun Wu · Wuxi, CN
Zhenzhong WANG · 安丰镇, CN
Chenfeng ZHANG · 安丰镇, CN

Key dates

Filing date	Nov 13, 2018
Grant date	Jan 31, 2023
Priority date	—
Expiry date	Dec 1, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0019
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A Ginkgo diterpene lactone composition is provided. The extract can lower the neurological function score of a cerebral ischemia-reperfusion rat, reduce the cerebral ischemia area and the water content after brain tissue edema, improve SOD activity, and decrease the MDA content. The composition can inhibit rabbit platelet aggregation induced by PAF and ADP inducers at different time points so as to reduce the maximum aggregation rate. In addition, experiments show that the effect of each monomer compound in the Ginkgo diterpene lactone composition is significantly increased at certain proportion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.